vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and LEGALZOOM.COM, INC. (LZ). Click either name above to swap in a different company.

LEGALZOOM.COM, INC. is the larger business by last-quarter revenue ($190.3M vs $121.8M, roughly 1.6× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs 3.2%, a 1.0% gap on every dollar of revenue. On growth, LEGALZOOM.COM, INC. posted the faster year-over-year revenue change (17.7% vs -1.4%). LEGALZOOM.COM, INC. produced more free cash flow last quarter ($28.0M vs $517.0K). Over the past eight quarters, LEGALZOOM.COM, INC.'s revenue compounded faster (4.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

LegalZoom.com, Inc. is an American online legal technology and services company launched in 2001. It provides online legal services using an independent network of attorneys and the LegalZoom-owned law firm, LegalZoom Legal Services, as well as self-service technology and care specialists. Services include wills and living trusts, business compliance such as licenses and permits, copyright registrations, and trademark applications. The company also offers attorney referrals and registered age...

CLB vs LZ — Head-to-Head

Bigger by revenue
LZ
LZ
1.6× larger
LZ
$190.3M
$121.8M
CLB
Growing faster (revenue YoY)
LZ
LZ
+19.1% gap
LZ
17.7%
-1.4%
CLB
Higher net margin
CLB
CLB
1.0% more per $
CLB
4.2%
3.2%
LZ
More free cash flow
LZ
LZ
$27.5M more FCF
LZ
$28.0M
$517.0K
CLB
Faster 2-yr revenue CAGR
LZ
LZ
Annualised
LZ
4.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
LZ
LZ
Revenue
$121.8M
$190.3M
Net Profit
$5.1M
$6.1M
Gross Margin
67.6%
Operating Margin
1.5%
6.6%
Net Margin
4.2%
3.2%
Revenue YoY
-1.4%
17.7%
Net Profit YoY
-52.9%
EPS (diluted)
$0.11
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
LZ
LZ
Q1 26
$121.8M
Q4 25
$138.3M
$190.3M
Q3 25
$134.5M
$190.2M
Q2 25
$130.2M
$192.5M
Q1 25
$123.6M
$183.1M
Q4 24
$129.2M
$161.7M
Q3 24
$134.4M
$168.6M
Q2 24
$130.6M
$177.4M
Net Profit
CLB
CLB
LZ
LZ
Q1 26
$5.1M
Q4 25
$4.9M
$6.1M
Q3 25
$14.2M
$4.5M
Q2 25
$10.6M
$-266.0K
Q1 25
$-154.0K
$5.1M
Q4 24
$7.4M
$12.9M
Q3 24
$11.7M
$11.1M
Q2 24
$9.0M
$1.3M
Gross Margin
CLB
CLB
LZ
LZ
Q1 26
Q4 25
20.8%
67.6%
Q3 25
22.0%
67.3%
Q2 25
20.3%
65.0%
Q1 25
19.5%
63.7%
Q4 24
17.8%
67.0%
Q3 24
20.5%
67.5%
Q2 24
21.2%
64.1%
Operating Margin
CLB
CLB
LZ
LZ
Q1 26
1.5%
Q4 25
11.5%
6.6%
Q3 25
15.6%
3.4%
Q2 25
11.7%
-1.6%
Q1 25
3.6%
4.9%
Q4 24
11.0%
8.1%
Q3 24
14.7%
9.6%
Q2 24
12.3%
0.6%
Net Margin
CLB
CLB
LZ
LZ
Q1 26
4.2%
Q4 25
3.6%
3.2%
Q3 25
10.6%
2.4%
Q2 25
8.2%
-0.1%
Q1 25
-0.1%
2.8%
Q4 24
5.7%
7.9%
Q3 24
8.7%
6.6%
Q2 24
6.9%
0.7%
EPS (diluted)
CLB
CLB
LZ
LZ
Q1 26
$0.11
Q4 25
$0.11
$0.03
Q3 25
$0.30
$0.02
Q2 25
$0.22
$0.00
Q1 25
$0.00
$0.03
Q4 24
$0.15
$0.07
Q3 24
$0.25
$0.06
Q2 24
$0.19
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
LZ
LZ
Cash + ST InvestmentsLiquidity on hand
$22.8M
$203.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$171.9M
Total Assets
$587.7M
$511.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
LZ
LZ
Q1 26
$22.8M
Q4 25
$22.7M
$203.1M
Q3 25
$25.6M
$237.2M
Q2 25
$31.2M
$217.0M
Q1 25
$22.1M
$210.0M
Q4 24
$19.2M
$142.1M
Q3 24
$21.5M
$112.5M
Q2 24
$17.7M
$118.8M
Total Debt
CLB
CLB
LZ
LZ
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
LZ
LZ
Q1 26
$275.1M
Q4 25
$266.0M
$171.9M
Q3 25
$271.3M
$201.9M
Q2 25
$261.3M
$194.1M
Q1 25
$253.4M
$187.2M
Q4 24
$246.6M
$93.3M
Q3 24
$250.7M
$60.1M
Q2 24
$240.3M
$60.8M
Total Assets
CLB
CLB
LZ
LZ
Q1 26
$587.7M
Q4 25
$584.0M
$511.5M
Q3 25
$591.4M
$551.1M
Q2 25
$602.1M
$543.0M
Q1 25
$591.5M
$532.7M
Q4 24
$585.1M
$373.9M
Q3 24
$600.5M
$348.8M
Q2 24
$597.8M
$359.5M
Debt / Equity
CLB
CLB
LZ
LZ
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
LZ
LZ
Operating Cash FlowLast quarter
$4.0M
$34.1M
Free Cash FlowOCF − Capex
$517.0K
$28.0M
FCF MarginFCF / Revenue
0.4%
14.7%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
0.77×
5.63×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$147.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
LZ
LZ
Q1 26
$4.0M
Q4 25
$7.9M
$34.1M
Q3 25
$8.5M
$54.2M
Q2 25
$13.9M
$39.1M
Q1 25
$6.7M
$50.7M
Q4 24
$20.6M
$42.6M
Q3 24
$13.1M
$31.6M
Q2 24
$17.1M
$27.2M
Free Cash Flow
CLB
CLB
LZ
LZ
Q1 26
$517.0K
Q4 25
$5.0M
$28.0M
Q3 25
$6.5M
$47.0M
Q2 25
$10.4M
$31.6M
Q1 25
$3.9M
$41.3M
Q4 24
$17.4M
$35.9M
Q3 24
$10.4M
$22.0M
Q2 24
$14.3M
$17.4M
FCF Margin
CLB
CLB
LZ
LZ
Q1 26
0.4%
Q4 25
3.6%
14.7%
Q3 25
4.8%
24.7%
Q2 25
8.0%
16.4%
Q1 25
3.1%
22.6%
Q4 24
13.4%
22.2%
Q3 24
7.7%
13.0%
Q2 24
10.9%
9.8%
Capex Intensity
CLB
CLB
LZ
LZ
Q1 26
Q4 25
2.1%
3.2%
Q3 25
1.5%
3.8%
Q2 25
2.7%
3.9%
Q1 25
2.3%
5.1%
Q4 24
2.5%
4.1%
Q3 24
2.0%
5.7%
Q2 24
2.2%
5.6%
Cash Conversion
CLB
CLB
LZ
LZ
Q1 26
0.77×
Q4 25
1.61×
5.63×
Q3 25
0.60×
12.03×
Q2 25
1.31×
Q1 25
9.89×
Q4 24
2.78×
3.31×
Q3 24
1.12×
2.86×
Q2 24
1.90×
20.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons